Seqirus Receives Health Canada Approval for Expanded Age Indication of Its Cell-Based Quadrivalent Influenza Vaccine for People as Young as Six Months
/CNW/ -- Seqirus, a global leader in influenza prevention, announced today that it has received Health Canada approval of FLUCELVAX® QUAD (Influenza Vaccine),...
Rupesh Chawla Gillian Stafford Maria Tortoreto Canada National Advisory Committee On Immunization Canadian Pediatric Society National Advisory Committee On Immunization
Source: newswire.ca